Web Analytics

3 Latest Announced Rounds

  • $3,500,000
    Seed

    1 Investors

    Technology, Information and Internet
    Dec 20th, 2024
  • $5,619,170
    Series B

    1 Investors

    Research Services
    Dec 20th, 2024
  • $8,000,000
    Unknown

    5 Investors

    Computer & Network Security
    Dec 20th, 2024
$671.88M Raised in 44 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Lenoss Medical

start up
United States - Providence, Rhode Island
  • 19/12/2023
  • Unknown
  • Undisclosed Amount

Vertebral Body Augmentation involves surgical placement of an instrument to create a cavity within a fractured vertebral body, due to trauma or osteoporosis. When the cavity is created, a device is implanted to fill the void and provide stability to damaged vertebrae.

When a biologic is used to fill the cavity, a regenerative phenomenon occurs, new bone begins to grow – and gradual healing of the affected vertebrae is achieved.

When a chemical epoxy is used to fill the cavity, no healing occurs, and the epoxy is left in the patient's vertebrae. Even though the synthetic technique is widely used in industry, there are a variety of complications. First, the epoxy is known to migrate outside the defined cavity (~23%) predisposing the patient to the risk of embolisms. Secondly, no healing occurs within the fractured vertebrae. Third, the vertebrae can no longer be instrumented with pedicle screws if/when the patient will need additional surgery. The inability to instrument a vertebra may result in a more invasive procedure with a myriad of complications and comorbidities. The time and temperature sensitivity of the epoxy, the toxic out-gassing, and numerous instrumentation also makes for an undesirable OR experience.


Related People

Dom MesserliFounder

Dom Messerli United States - Greater Boston

I am an experienced Medical Device Executive, able to build highly effective teams and lead them to achieve innovative, timely and profitable, global medical device product introductions. I consistently enable U.S. and European staff to achieve departmental and personal goals amidst significant organizational change and uncertainty. I have proven and I immensely enjoy enabling my staff to perform above expectations and reach their professional goals and aspirations ahead of their peers. My core leadership skills and core competencies include:

- Medical Device Product Development & Marketing
- Business Unit Creation & Leadership
- Global Talent Management, U.S.A and Europe (acquisition/development/promotion)
- Change Management
- Mergers & Acquisitions & External Partnerships
- Intellectual Property Strategy & Protection
- FDA Strategy & Clearance